Atlas Trials

UCB Biopharma S.P.R.L.

48 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch UCB Biopharma S.P.R.L.

RecordFirmDate
A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function (NCT04136444)UCB Biopharma S.P.R.L.2019-10-28
A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants (NCT04126343)UCB Biopharma S.P.R.L.2019-10-23
A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants (NCT04075409)UCB Biopharma S.P.R.L.2019-09-30
A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol (NCT04039919)UCB Biopharma S.P.R.L.2019-07-17
A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants (NCT04013191)UCB Biopharma S.P.R.L.2019-07-09
A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD) (NCT04875962)UCB Biopharma S.P.R.L.2019-05-06
A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects (NCT03895385)UCB Biopharma S.P.R.L.2019-04-02
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT03861481)UCB Biopharma S.P.R.L.2019-03-26
A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants (NCT03859219)UCB Biopharma S.P.R.L.2019-03-18
A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization (NCT03685630)UCB Biopharma S.P.R.L.2019-01-04
A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants (NCT03707717)UCB Biopharma S.P.R.L.2018-10-15
A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil (NCT03695094)UCB Biopharma S.P.R.L.2018-09-18
A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects (NCT03605082)UCB Biopharma S.P.R.L.2018-07-25
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy (NCT03405714)UCB Biopharma S.P.R.L.2018-06-01
Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil (NCT03480243)UCB Biopharma S.P.R.L.2018-03-27
A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male Subjects (NCT03464227)UCB Biopharma S.P.R.L.2018-02-16
Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy (NCT03373383)UCB Biopharma S.P.R.L.2018-02-12
A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS) (NCT02829827)UCB Biopharma S.P.R.L.2017-12-04

Track UCB Biopharma S.P.R.L. automatically

Every clearance here is in the API, with alerts when new ones post.